<SEC-DOCUMENT>0001213900-21-000823-index.html : 20210107 <SEC-HEADER>0001213900-21-000823.hdr.sgml : 20210107 <ACCEPTANCE-DATETIME>20210107102119 ACCESSION NUMBER: 0001213900-21-000823 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210107 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210107 DATE AS OF CHANGE: 20210107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCELL CORP /DE/ CENTRAL INDEX KEY: 0000811641 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010382980 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12934 FILM NUMBER: 21513255 BUSINESS ADDRESS: STREET 1: 56 EVERGREEN DR CITY: PORTLAND STATE: ME ZIP: 04103 BUSINESS PHONE: 2078782770 MAIL ADDRESS: STREET 1: 56 EVERGREEN DRIVE CITY: PORTLAND STATE: ME ZIP: 04103 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>ea132883-8k_immucell.htm <DESCRIPTION>CURRENT REPORT <TEXT> Document 1 - file: ea132883-8k_immucell.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ea132883ex99-1_immucell.htm <DESCRIPTION>PRESS RELEASE OF IMMUCELL CORPORATION DATED JANUARY 7, 2021 <TEXT> Document 2 - file: ea132883ex99-1_immucell.htm
</DOCUMENT> </SEC-DOCUMENT>